Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection Academic Article Article uri icon

Overview

MeSH Major

  • Immunotherapy
  • T-Lymphocyte Subsets
  • T-Lymphocytes, Regulatory

abstract

  • Our data indicated that treatment with anti-p40 inhibited Th1- and Th17-cell responses and prolonged the survival of cardiac allografts in mice.

publication date

  • January 15, 2011

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1097/TP.0b013e3181fdd948

PubMed ID

  • 21452409

Additional Document Info

start page

  • 27

end page

  • 34

volume

  • 91

number

  • 1